Discovery of 1-aryloxyethyl piperazine derivatives as Kv1.5 potassium channel inhibitors (part I). [electronic resource]
Producer: 20150330Description: 89-94 p. digitalISSN:- 1768-3254
- Administration, Intravenous
- Animals
- Atrial Fibrillation -- drug therapy
- Dose-Response Relationship, Drug
- Drug Discovery
- HEK293 Cells
- Humans
- Kv1.5 Potassium Channel -- antagonists & inhibitors
- Mice
- Molecular Structure
- Piperazines -- administration & dosage
- Rats
- Rats, Sprague-Dawley
- Structure-Activity Relationship
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.